Scientists tested in monkeys effective anti-Ebola vaccine

Untitled
The researchers indicated that this new vaccine can be modified so that it can be manufactured in eight weeks. | Photo: Archive

A group of scientists from the Medical Unit of the University of Texas, USA, tested the effectiveness of a vaccine against Ebola.

The experimental drug for TKM virus was practiced in six rhesus monkeys infected Makona Guinea strain that caused the outbreak of Ebola in West Africa.

The study was published today in the British journal Nature, where scientists said the drug is able to protect one hundred percent against the deadly disease to primates when treatment begins “three days after exposure, while the animals were viral and clinically ill “.”Although all infected animals showed signs of advanced disease-including hematologic abnormality, blood chemistry and coagulopatía-, those treated developed milder medical conditions and fully recovered, while the untreated succumbed to the disease,” they said in research .

However, note that this new vaccine can be modified to act on a specific strain of Ebola virus and can be manufactured in eight weeks.

The Data
The current epidemic has infected more than 25 thousand 700 people, of which 10 000 600 have died.Read also:
WHO admits that his response was insufficient Ebola
Cuba congratulates doctors who treated Ebola in West Africa

In context:
The first case of Ebola occurred in December 2013 in Guinea Conakry but no one knew who had an outbreak until March 2014 and soon became known that the virus had crossed the borders of Guinea and had expanded to Liberia and Sierra Leone .
The WHO said no initially be prepared for an emergency international scale, assuming also that it did not sufficiently take into account the cultural aspects of the region where the outbreak occurred.